Barings’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Barings’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,400	Closed	-$223K	–	1025
2015 Q2	$223K	Buy	+5,400	New	+$194K	0.01%	897

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Barings's BRLI Position: Q3 2015 in Review

Barings sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 5,400 shares — an estimated $223K sold.

Barings first reported a position in BRLI in Q2 2015 and held it in 1 quarter. The position peaked at $223K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Barings reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Barings sold 5,400 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $223K.
Barings first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2015 and held it in 1 quarter.
Barings's BIO-REFERENCE LABS INC-NEW- position peaked at $223K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Barings's 13F filing for Q3 2015, filed 2 Nov 2015.